RxDoctor Payments Data

Meaghan Brown

Family · Flemington, NJNPI 1104296128

Payments from drug & device makers

$1,970in general payments, 2019–2025

Across 97 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$260
  • Amgen$234
  • Edwards Lifesciences$221
  • Boston Scientific$201
  • E.r. Squibb & Sons, L.L.C.$181
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$159
  • plus $714 from 19 others

What the payments were for

  • Food & beverage$1,970100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,970 in reported general payments places this provider in the 85th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban117$106,040
XareltoRivaroxaban33$28,797
Metoprolol Succinate193$3,345
Diltiazem 24hr Er (La)Diltiazem Hcl17$2,601
Midodrine Hcl17$2,281
Candesartan Cilexetil15$1,641
Amlodipine Besylate160$1,054
Diltiazem 24hr Er (Cd)Diltiazem Hcl40$955
Atorvastatin Calcium73$853
Carvedilol72$712
Rosuvastatin Calcium63$706
Amiodarone Hcl20$581
Valsartan15$528
Digoxin14$503
Losartan Potassium35$428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$54$28,79733 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,692 family providers in New Jersey.

Other family in Flemington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →